-
Mashup Score: 9Mitigating acute chemotherapy-associated adverse events in patients with cancer - Nature Reviews Clinical Oncology - 1 year(s) ago
Either alone or in combination, chemotherapy remains the mainstay treatment for most human malignancies. This treatment modality is associated with a high burden of chemotherapy-associated adverse events (CAAEs) that greatly affect patients because of their considerable morbidity, mortality and costs. Kuderer et al. discuss the pathophysiology, management and risk factors of the most common acute…
Source: NatureCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Nurse Researchers Make The Case For “Real-Time Toxicity” Teams in Bone Marrow Transplantation - 1 year(s) ago
Linh Nguyen BSN, RN, OCN, BMTCN, highlights the benefits of prospective toxicity data collection for patients undergoing bone marrow transplantation.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Linh Nguyen BSN, RN, OCN, BMTCN, highlights the benefits of prospective toxicity data collection for patients undergoing bone marrow transplantation. #BMT #toxicity #oncolgoy #nursing #ASTCT @MSKCancerCenter https://t.co/2fOsmGyv1W
-
-
Mashup Score: 0Nurse Researchers Make The Case For “Real-Time Toxicity” Teams in Bone Marrow Transplantation - 1 year(s) ago
Linh Nguyen BSN, RN, OCN, BMTCN, highlights the benefits of prospective toxicity data collection for patients undergoing bone marrow transplantation.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Nurse Researchers Make The Case For “Real-Time Toxicity” Teams in Bone Marrow Transplantation #BMT #toxicity #oncolgoy #nursing #ASTCT @MSKCancerCenter https://t.co/8CPsYgVCLB
-
-
Mashup Score: 0Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Emergency Medicine, Latest HeadlinesTweet-
Understanding the #toxicity of #abortifacients is vital, but do you know about toxic birds? @poisonreview delves into important articles from 2022 including one about our fine feathered friends that carry poisonous compounds. Say what now??? https://t.co/vG5Z2N5gkl https://t.co/kEMImrdb2N
-
-
Mashup Score: 0Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Emergency Medicine, Latest HeadlinesTweet-
Understanding the #toxicity of #abortifacients is vital, but do you know about toxic birds? @poisonreview delves into important articles from 2022 including one about our fine feathered friends that carry poisonous compounds. Say what now??? https://t.co/vG5Z2N5gkl https://t.co/jEwYkfrkCU
-
-
Mashup Score: 0Researchers Identify 28 Early Signs of CAR T-Cell Toxicity - 1 year(s) ago
Researchers say they have identified 28 signs and symptoms that can facilitate early recognition of toxicity associated with CAR T-cell therapy.
Source: Oncology Nurse AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Researchers say they have identified 28 signs and symptoms that can facilitate early recognition of #toxicity associated with #CARTcellTherapy. The findings were published in @JCOOP_ASCO and @CancerTherAdvsr. https://t.co/0wmRy0pIxk
-
-
Mashup Score: 5ICOP-Pharm: could the new paradigm bridge a gap in evidence raised by 2022 ESC guidelines on cardio-oncology? - 1 year(s) ago
Cardio-oncology is an emerging subspecialty in the field of cardiology that is based on a multidisciplinary approach.1 Although pharmacists play an essential ro
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
ICOP-Pharm: could the new paradigm bridge a gap in evidence raised by 2022 ESC guidelines on cardio-oncology? https://t.co/pgZZH3Ynqj #cardiooncology #guidelines #CVD #cancer #therapy #toxicity #cardiotwitter @escardio @ESC_Journals https://t.co/UREIleUyR5
-
-
Mashup Score: 0Mechanisms, mitigation, and management of urinary toxicity from prostate radiotherapy - 1 year(s) ago
Urinary toxicity is common following pelvic radiotherapy and can have a substantial negative effect on survivorship. Due to its prevalence and the increasing number of related clinical trials, localised prostate cancer radiotherapy is a useful illustrative tool to explore urinary toxicity. A good understanding of the interplay between anatomy, radiation-sensitive cell populations, and treatment…
Source: The Lancet OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
New December issue Review: Mechanisms, mitigation, and management of #urinary #toxicity from #prostate #radiotherapy https://t.co/eBArceWBm7
-
-
Mashup Score: 6Linking the European Organisation for Research and Treatment of Cancer Item Library to the Common Terminology Criteria for Adverse Events - 2 year(s) ago
PURPOSE The European Organisation for Research and Treatment of Cancer (EORTC) Item Library is an interactive online platform currently composed of 950 unique items (questions) derived from 67 patient-reported outcome (PRO) questionnaires. PROs complement clinician adverse event (AE) reporting classifications like the Common Terminology Criteria for Adverse Events (CTCAE). This work aims to…
Source: Journal of Clinical OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🚨 #JCO #SpecialArticle: Linking the European Organisation for Research and Treatment of Cancer (@EORTC) item library to the Common Terminology Criteria for Adverse Events (#CTCAE) ➡️ https://t.co/QmUAqQsu5f #toxicity #QOL #supponc @andrewbottom0 https://t.co/QQZKCPyuJh
-
-
Mashup Score: 0
PURPOSE Patients with advanced or metastatic esophageal squamous cell carcinoma (ESCC) have poor prognosis. For these patients, treatment options are limited after first-line systemic therapy. PATIENTS AND METHODS In this open-label phase III clinical study, patients with advanced or metastatic ESCC, whose tumor progressed after first-line systemic treatment, were randomly assigned (1:1) to…
Source: Journal of Clinical OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
RATIONALE 302: Tislelizumab vs #chemotherapy as 2nd-line Tx for advanced/metastatic squamous cell #EsophagealCarcinoma: Tislelizumab improved overall survival vs chemo (med 8.6 v 6.3 mos; HR 0.70 [95% CI, 0.57 - 0.85] 🤗 Tislelizumab had ⬇️ G3 #toxicity! https://t.co/mkPUDqgaNy https://t.co/S5WLHQbFKx
-
Here are some great reads to make the best of your #AACR23 experience. @NatRevClinOncol has contributed to this comprehensive collection with a Review on #toxicity from @gary_lyman @NicoleKuderer @ADesaiMD and @maryam_lustberg https://t.co/WUcOXGTbja https://t.co/6waZa6FzyQ